13F Holdings
中文EN

EHC Encompass Health Corp

Services-Hospitals · NYSE · SEC CIK 785161 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.4%
TTM net income YoY19.1%
TTM EPS YoY21.0%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR22.1%

Margins

Gross margin—
Operating margin—
Net margin10.2%
FCF margin7.2%
EBITDA margin—

Returns

ROE25.5%
ROA8.9%
ROIC (approx.)—
Asset turnover0.88x

Leverage & solvency

Liabilities / assets52.9%
Debt / equity0.97x
Current ratio1.09x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.02x
Accruals ratio-9.1%
Payout ratio11.9%
Capex / revenue13.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$5.94B$5.37B$4.80B$4.35B$4.01B
SG&A expense$236.20M$209.20M$201.70M$154.30M$169.50M
Operating income———$539.50M$559.60M
Interest expense$123.20M$137.40M$143.50M$175.70M$164.30M
Pretax income$953.00M$749.60M$607.20M$450.80M$505.00M
Income tax$192.90M$150.20M$132.20M$100.10M$101.90M
Net income$566.20M$455.70M$352.00M$271.00M$412.20M
EBITDA———$783.10M$779.20M
EPS (basic)5.624.533.512.724.15
EPS (diluted)5.544.463.472.704.11
Dividends declared per share0.720.640.600.861.12
Weighted avg. shares (diluted)102.20M102.20M101.30M100.40M100.20M
Balance sheet
Cash & equivalents$72.20M$85.40M$69.10M$21.80M$49.40M
Receivables$619.20M$593.00M$599.80M$524.80M$502.10M
Current assets$905.90M$886.90M$841.80M$717.20M$921.40M
PP&E, net$4.10B$3.64B$3.30B$2.94B$2.58B
Goodwill$1.32B$1.28B$1.28B$1.26B$1.24B
Intangibles$308.30M$297.80M$278.20M$282.30M$158.40M
Total assets$7.09B$6.53B$6.10B$5.64B$6.86B
Current liabilities$836.40M$841.00M$656.40M$575.90M$748.80M
Short-term debt$43.60M$138.60M$24.80M$25.20M$37.80M
Long-term debt$2.45B$2.36B$2.69B$2.74B$3.24B
Total debt$2.49B$2.50B$2.71B$2.77B$3.28B
Total liabilities$3.81B$3.69B$3.81B$3.77B$4.47B
Shareholders' equity$2.44B$2.07B$1.65B$1.31B$1.91B
Net debt$2.42B$2.41B$2.64B$2.75B$3.23B
Cash flow statement
Operating cash flow$1.18B$1.00B$850.80M$705.80M$715.80M
Capital expenditure$736.40M$642.50M$583.10M$584.10M$545.70M
Free cash flow$439.20M$360.30M$267.70M$121.70M$170.10M
Investing cash flow-$764.60M-$653.30M-$602.80M-$627.00M-$666.30M
Financing cash flow-$431.20M-$330.60M-$197.20M-$145.70M-$240.10M
Depreciation & amortization$327.90M$299.60M$273.90M$243.60M$219.60M
Stock-based compensation$56.50M$48.30M$50.60M$29.20M$29.10M
Dividends paid$71.10M$62.80M$60.40M$99.00M$112.20M
Share buybacks$158.00M$31.10M$0$0$0

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.